Swissmedic approves Ameluz® in combination with daylight photodynamic therapy in Switzerland
01. Oktober 2018 09:08 ET
|
Biofrontera AG
Leverkusen, Germany, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, announced today that Swissmedic, the...